Skip to main content

Abstract

Background—

For migrant populations from sub-Saharan Africa, adverse cardiovascular disease (CVD) risk factors have been observed to be higher than found in their home country-based counterparts or among the host populations in high-income countries. Differences in absolute overall CVD risk, however, remain largely unexplained. We, therefore, predicted the differences in 10-year CVD risk among sub-Saharan African migrants (Ghanaians) living in 3 European cities and Ghana.

Methods and Results—

For 3864 subjects aged 40 to 70 years from the multicenter RODAM study (Research on Obesity and Diabetes Among African Migrants) conducted among Ghanaian adults residing in rural and urban Ghana and 3 European cities (Amsterdam, Berlin, and London), 10-year risk of CVD was estimated using the Pooled Cohort Equations with estimates ≥7.5% defining high CVD risk. Logistic regressions were used to determine the association of migration on CVD risk. The proportion with CVD risk ≥7.5% among Ghanaian men was 34.7% in rural Ghana, 45.4% in urban Ghana, 53.9% in Amsterdam, 61.0% in Berlin, and 52.2% in London. Compared with rural Ghana, CVD risk was significantly increased for Ghanaian men living in Berlin (adjusted odds ratio, 2.80; 95% confidence interval, 1.76–4.45) and Amsterdam (1.88; 1.25–2.84). Increased risk observed for men was largely not seen for women. CVD risk increased with longer stay in Europe.

Conclusions—

Knowledge about predictors of increased CVD risk among sub-Saharan African migrants in Europe and nonmigrants in urban centers will inform and support targeted health care and interventions to these populations.

Introduction

WHAT IS KNOWN

Migrant populations from sub-Saharan Africa to high-income countries are at a higher risk of developing adverse cardiovascular (CVD) risk factors than their home country-based counterparts or the host populations in their new countries.

WHAT THE STUDY ADDS

This study shows that absolute 10-year CVD risk is higher among Ghanaian men residing in urban centers in Europe and Ghana than their rural Ghana counterparts.
CVD risk among Ghanaian men residing in Europe differed according to city of residency and increased with longer stay in Europe.
Increased CVD risk observed for Ghanaian men in Europe was largely not seen for women.
Contributory CVD risk factors in Ghanian men included elevated blood pressure, diabetes mellitus, smoking, lower physical activity, and greater obesity, as well as potential differences in socioeconomic positions.
Migrants’ health is an important public health issue1 with growing evidence supporting the role of migration in the development of noncommunicable diseases.24 Migrant populations from sub-Saharan Africa (SSA) seem to be affected disproportionately by cardiovascular diseases (CVDs) and related risk factors, including hypertension, obesity, and diabetes mellitus.5,6 For instance, the prevalence of hypertension in The Netherlands relative to Dutch people is higher in all ethnic minority groups, with the exception of Moroccan women.7 Evidence from Canada, however, shows better CVD risk profile among migrants than the host population.8 This shows the importance of diverse factors (including acculturative stress resulting from the feeling of isolation, discrimination, alienation and dislocation,9 lifestyle changes and adaptations,10 and access to health care) in explaining the differences in CVD risk among migrant populations.
Migrant populations carry along disease characteristics, inherited from their place of origin,11 which affect future risk of CVD. The CVD risk profile among migrant populations, however, may change over time as they get exposed to the factors of their host environment.12 This results in differences in CVD risk between similar populations residing in different industrialized countries. For instance, Agyemang et al13 found that people of African descent residing in England had a lower prevalence of type 2 diabetes mellitus than those residing in The Netherlands, and these differences reflected the difference in prevalence of CVDs of their host countries.14 The reasons for these differences are unclear but could include cross-national differences in health behaviors and related factors, such as socioeconomic position, accessibility, and utilization of preventive services.13,15
CVDs reflect the combined effect of several risk factors,16 which tend to appear in clusters.17 Current guidelines for CVD risk reduction have, therefore, reiterated the need to assess all risk factors as a more effective basis to deliver CVD prevention interventions.16 Absolute CVD risk estimates, using established risk algorithms, help to determine the probability of a cardiovascular event occurring within a specified time horizon.
Most established CVD risk algorithms, however, do not appropriately capture the ethnic and socioeconomic disparities relating to CVDs.18,19 Distinctive levels of risk factors among various ethnic groups contribute significantly to differences in CVD,20 making ethnicity an important parameter when estimating CVD risk. The pooled cohort equations (PCE), developed and validated among Black and European and Asian men and women, have been shown to be comparatively more precise in estimating CVD risk.21 The equations are derived using pooled data from ethnically and geographically diverse community-based cohorts, permitting the creation of sex- and ethnic-specific equations for non-Hispanic White American and Black women and men.22
Because most studies on CVDs among African migrant populations have focused on individual risk factors, this study, as part of the RODAM study (Research on Obesity and Diabetes Among African Migrants),23,24 sought to (1) assess the potential role of migration on CVD risk by assessing the differences in 10-year estimated CVD risk among nonmigrant Ghanaians living in rural and urban Ghana and Ghanaian migrants living in 3 different European countries using the PCE algorithms and (2) assess the modifiable risk factors that predispose them to poor CVD outcomes in their host countries.

Methods

Study Design and Population

Details of the multicenter RODAM study, including statistical power, sample size estimations, sampling, recruitment, and measurements, are published elsewhere.24 In brief, in the RODAM study, 6385 Ghanaians from a homogenous population residing in Ghana or had migrated to different European countries were recruited, of whom 5898 were physically examined. As a central feature of the RODAM study, at all study sites, a well-standardized approach was used for data collection. In Ghana, 2 purposively chosen cities and 15 villages in the Ashanti region were used as the urban and rural recruitment sites, respectively. The response rates were 76% in rural Ghana and 74% in urban Ghana. In Amsterdam, 67% replied by response card or after a home visit. Of these, 53% agreed and participated in the study. In London, of those individuals who were invited based on their registration in Ghanaian organizations, 75% agreed and participated in the study. In Berlin, this figure was 68%. For the current analysis, all RODAM study subjects aged 40 to 70 years who had provided informed consent and without history of clinical CVD (n=3864) were included. Missing biomedical and sociodemographic data (systolic blood pressure [BP; 0.3%], cholesterol [3.6%], high-density lipoprotein cholesterol [3.6%], low-density lipoprotein cholesterol [3.7%], smoking [1.1%], and employment [8%]) were excluded from the analysis.

Recruitment and Sampling

The definition of a Ghanaian for this study was to have been either born in Ghana and have either one or both parents born in Ghana (in case of migrants, first generation) or if not born in Ghana, have both parents born in Ghana (in case of migrants, second generation). Recruitment strategies for the various locations differed according to population registration systems across European countries and in Ghana. The study was approved by the respective ethics committees at all the study sites.

Measurements

Information on demographics, educational level, and migration histories was obtained by structured questionnaire. Concentration of total cholesterol was assessed using colorimetric test kits. All biochemical analyses were performed at Berlin with an ABX Pentra 400 chemistry analyzer (ABX Pentra; Horiba ABX, Germany). Type 2 diabetes mellitus was defined according to the World Health Organization diagnostic criteria (fasting glucose, ≥7.0 mmol/L, or current use of medication prescribed to treat diabetes mellitus or self-reported diabetes mellitus).24 Using validated semiautomated device (Microlife WatchBP home), BP was measured 3× using appropriate cuffs in a sitting position after at least 5 minutes of rest. The mean of the last 2 measurements was used in the analysis. Body mass index (BMI) was calculated as weight (kg) divided by height squared (m2). Overweight and obesity were defined as 25≤BMI<30 kg/m2 and BMI ≥30 kg/m2, respectively.25 Physical activity was assessed using the World Health Organization Global Physical Activity Questionnaire26 and categorized into high, medium, and low levels of physical activity. The level of psychosocial stress was assessed from a combined score distinguishing between participants’ level of stress at work and at home (never experienced stress/experienced some periods of stress at work or at home or experienced several periods of stress/permanent stress at work or at home).

10-Year CVD Risk

The outcome variable was predicted 10-year CVD risk as estimated from the PCE equations for Black men and women. This model combines age, sex, total cholesterol, high-density lipoprotein cholesterol, systolic BP, use of antihypertensive medication, diagnosed with diabetes mellitus, and smoking to estimate the 10-year absolute risk of CVD in people without preexisting CVD.22 In their updated clinical practice guidelines for the treatment of blood cholesterol to reduce atherosclerotic CVD, the American College of Cardiology and American Heart Association recommended the PCE as a novel tool to estimate 10-year CVD risk.27 The guidelines provide a strong recommendation (class I, level of evidence: A) for consideration of statin treatment in individuals with a 10-year CVD risk ≥7.5% and a moderate recommendation (class IIa, level of evidence: B) in individuals with a 10-year CVD risk of 5% to <7.5%. Predicted CVD risk was categorized into <5%, 5% to <7.5%, 7.5% to <10%, 10% to <15%, 15% to <20%, and ≥20%. CVD risk ≥7.5% was considered as elevated risk of CVD based on the prior work by Goff et al.22 Determinants were migration-related factors (international migration and length of stay in Europe). Other covariates assessed were education, employment, and sources of income.

Data Analysis

General characteristics are summarized as proportions, mean, and median values. Comparisons across recruitment sites used χ2 test, ANOVA, and Kruskal–Wallis tests as appropriate. Post hoc pairwise comparisons after ANOVA and Kruskal–Wallis tests were conducted by use of the Tukey honest significant difference test and Dunn test for multiple comparison, respectively. The distribution of the predicted CVD risk was examined via density curves, separately by recruitment sites using the Epanechnikov kernel function in STATA (Stata Corp, College Station, TX). Logistic regression models were used to assess the influence of migration-related factors on the odds of elevated CVD risk. Three models were fitted to adjust for possible confounders: model 1, education, employment, and sources of income; model 2: model 1+physical activity and alcohol; and model 3: model 2+psychosocial stress. A logistic postestimation checked for the equality of coefficients for the European cities (and urban Ghana). To assess the influence of length of migration on elevated CVD risk, 2 adjusted models were fitted: model 1 for age and model 2 for age, education, employment, and sources of income. The analyses were stratified by sex after realizing differences in risk factor profiles by sex. All statistical tests were conducted at a significance level of P<0.05. Data were analyzed with SPSS, version 22.

Results

General Characteristics and Risk Factor Profile

With the exception of Berlin (where 54.8% were men), the majority of the subjects at the various sites were women (Amsterdam, 57.7%; London, 64.5%; urban Ghana, 70.2%; and rural Ghana, 62.76%; P<0.001; Table I in the Data Supplement). Educational level was highest in London and lowest in rural Ghana, where 45.7% of men and 71.1% of women had no formal or only elementary education. The majority of the subjects from all sites were used, either full or part-time. Ghanaians residing in Amsterdam reported the highest proportion on social benefits. On average, median duration of stay among Ghanaians in the European sites was 21 years for both men and women.
As shown in Table 1, men were generally older than women at all sites with the exception of London. Mean systolic BP among men was significantly higher in Berlin than in urban (P=0.001) and rural Ghana (P<0.001) but not significantly different from Amsterdam and London. Mean total cholesterol and high-density lipoprotein cholesterol were significantly higher in Berlin than at all sites with the exception of urban Ghana. Mean low-density lipoprotein was significantly higher in urban Ghana than all sites with the exception of Berlin. Mean BMI (SEM) among men was 25.7 (0.1) and was significantly higher in London, 27.8 (0.2) compared with the other sites. Smoking and obesity were significantly higher in Berlin, whereas diabetes mellitus was significantly lower in rural Ghana. Among women, mean systolic BP was significantly higher in London than all sites except Berlin and lowest in rural Ghana. Mean total and low-density lipoprotein cholesterol were highest among women from urban Ghana than all sites. Similar to men, the proportions of type 2 diabetes mellitus were significantly lower in rural Ghana, whereas the percentage of current smokers was highest in Berlin. Mean BMI (SEM) was 29.0 (0.1) and significantly higher in London, 31.4 (0.2) compared with the other sites. Alcohol intake among women was significantly higher in urban Ghana and lower in Amsterdam.
Table 1. Risk Factor Profile Overall and Across RODAM by Study Sites
VariablesTotal (n=3864)Study SiteP Value
Rural Ghana (n=633)Urban Ghana (n=916)Amsterdam (n=1176)Berlin (n=365)London (n=774)
Men, N1481236273497200275 
 Age, y52±0.253±0.553±0.552±0.952±0.552±0.40.049
 Mean systolic BP136.5±0.5126.0±1.2134.5±1.3139.5±0.8141.3±1.3138.5±1.1<0.001
 BP medication, N (%)345 (23.3)13 (5.5)22 (8.1)157 (31.6)75 (37.5)78 (28.4)<0.001
 Total cholesterol, mmol/L5.00±0.034.2±0.15.2±0.15.1±0.055.3±0.15.0±0.1<0.001
 LDL cholesterol, mmol/L3.2±0.022.5±0.13.5±0.13.3±0.043.3±0.13.3±01<0.001
 HDL cholesterol, mmol/L1.3±0.011.2±0.021.2±0.021.3±0.011.4±0.021.3±0.02<0.001
 Type 2 diabetes mellitus, N (%)*204 (13.8)11 (4.7)40 (14.7)79 (15.9)37 (18.5)37 (13.5)<0.001
 Smoking, N (%)       
  Current91 (6.6)17 (7.7)8 (3.1)33 (7.3)31 (15.5)2 (0.8)<0.001
  Past225 (16.3)46 (20.8)52 (20.2)67 (14.8)395 (17.5)25 (10.0) 
 BMI, kg/m2, ≥30, N (%)215 (14.5)2 (0.8)21 (7.7)96 (23.8)33 (16.5)63 (22.9)<0.001
 High-level physical activity, N (%)667 (45.0)156 (66.1)138 (50.5)193 (38.8)104 (52.0)72 (27.6)<0.001
 Psychosocial stress: home and work, N (%)       
  Never experienced606 (44.4)50 (23.0)97 (37.9)241 (53.3)103 (51.5)111 (48.3)<0.001
  Permanent stress48 (3.5)5 (2.3)3 (1.2)28 (6.2)6 (3.0)6 (2.6) 
 Alcohol consumption, N (%)525 (35.4)76 (32.2)101 (37.0)189 (38.0)66 (33.0)93 (33.8)0.454
 10-y CVD risk, N (%)       
  <5289 (27.3)96 (34.6)93 (34.6)95 (20.5)37 (18.5)68 (26.1)<0.001
  5–7.5328 (23.0)55 (23.8)55 (20.4)119 (25.6)42 (21.0)57 (21.8) 
  7.5–10210 (14.7)22 (9.5)38 (14.1)69 (14.9)33 (16.5)48 (18.4) 
  10–15259 (18.2)42 (18.2)37 (13.8)96 (20.7)42 (21.0)42 (16.1) 
  15–20121 (8.5)14 (6.1)23 (8.6)41 (8.8)17 (8.5)26 (10.0) 
  >20118 (8.3)2 (0.9)23 (8.6)44 (9.5)29 (14.5)20 (7.7) 
Women, N2383397643679165499 
 Age, y51±0.152±0.451±0.350±0.250±0.552±0.3<0.001
 Mean systolic BP, mm Hg132.4±0.4126.5±1.1128.9±0.7134.9±0.7135.1±1.3137.4±0.7<0.001
 BP medication, N (%)649 (27.2)42 (10.6)109 (17.0)249 (36.7)69 (41.8)180 (36.1)<0.001
 Total cholesterol, mmol/L5.1±0.024.8±0.15.4±0.045.1±0.045.2±0.15.1±0.04<0.001
 LDL cholesterol, mmol/L3.3±0.023.1±0.053.7±0.043.3±0.033.3±0.13.2±0.04<0.001
 HDL cholesterol, mmol/L1.4±0.011.2±0.021.3±0.011.5±0.011.6±0.031.5±0.01<0.001
 Type 2 diabetes mellitus, N (%)*241 (10.1)24 (6.0)68 (10.6)76 (11.2)19 (11.5)54 (10.8)<0.001
 Smoking, N (%)       
  Current18 (0.8)0 (0)0 (0.0)13 (2.1)5 (3.1)0 (0)<0.001
  Past83 (3.7)3 (0.8)16 (2.6)40 (6.5)11 (6.8)13 (3.0) 
 BMI, kg/m2, ≥30, N (%)984 (41.4)37 (9.3)233 (36.2)359 (53.0)66 (40.0)289 (58.6)<0.001
 High-level physical activity, N (%)912 (38.3)198 (49.9)260 (38.7)263 (46.1)76 (46.1)115 (23.0) 
 Psychosocial stress: home and work, N (%)       
  Never experienced878 (38.8)75 (20.5)184 (29.8)280 (46.4)70 (43.5)228 (55.3)<0.001
  Permanent stress65 (3.0)9 (2.5)7 (1.1)31 (5.1)10 (6.2)8 (1.9) 
 Alcohol consumption, N (%)835 (35.0)138 (34.8)257 (40.0)218 (32.1)64 (38.8)158 (31.7)0.011
 10-y CVD risk, N (%)       
  <51494 (66.7)266 (69.3)427 (67.2)418 (68.9)114 (69.5)269 (59.8)0.155
  5–7.5271 (12.1)44 (11.5)69 (10.9)73 (12.0)19 (11.6)66 (14.7) 
  7.5–10178 (7.9)27 (7.0)47 (7.4)49 (8.1)14 (8.5)41 (9.1) 
  10–15165 (7.4)27 (7.0)50 (7.9)38 (6.3)7 (4.3)43 (9.6) 
  15–2074 (3.3)14 (3.6)26 (4.1)18 (3.0)4 (2.4)12 (2.7) 
  >2058 (2.6)6 (1.6)16 (2.5)11 (1.8)6 (3.7)19 (4.2) 
BMI indicates body mass index; BP, blood pressure; CVD, cardiovascular disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein; and WHO, World Health Organization.
*
Based on self-report, use of hypoglycemic medication or fasting plasma glucose, ≥7 mmol/L (WHO criteria); Data presented as means±SEM unless stated otherwise.

10-Year CVD Risk for Fatal and Nonfatal Events

Distributions of 10-year CVD risk scores per study sites are given in Figure I in the Data Supplement. Peak density corresponded with a much higher CVD risk score for Berlin and lower score for rural Ghana. A Kruskal–Wallis test showed a statistically significant difference in the distribution of CVD risk score between the various sites (P<0.001).
The proportion of subjects with ≥20% 10-year risk of CVD was highest in Berlin (15%) and lowest in rural Ghana (0.9%) for men, respectively. Elevated 10-year risk of CVD (≥7.5%) among men was equally higher in Berlin (61.0%) and lowest in rural Ghana (35.6%), P<0.001. However, among women, there was no significant difference in CVD risk between the various sites (Table 1). In general, the CVD risk predictions were higher in men than in women, with the exception of rural Ghana, where CVD risk of ≥20% was 1.6% among women and 0.9% among men.

Influence of Migration on 10-Year CVD Risk, RODAM Study

Two models were built, to control for education (model 1) and education, employment, and income (model 2). Ghanaian migrants in urban Ghana and European cities had increased propensity to be at elevated CVD risk as compared with their rural Ghana counterparts. Compared with men in rural Ghana, the univariable results showed ≈3× higher odds of elevated CVD risk for those living in Berlin (odds ratio [OR], 2.97; 95% confidence interval [CI], 2.00–4.40; Figure 1). Adjustment for possible confounders only slightly attenuated the association. The odds of elevated CVD risk were also significantly higher for Ghanaian men living in Amsterdam (OR, 2.21; 95% CI, 1.59–3.06) and urban Ghana (OR, 1.57; 95% CI, 1.09–2.25), with only minor changes after adjustment for education, employment, and sources of income. A post-estimation test showed that the coefficients for urban Ghana differed significantly from those for Berlin and Amsterdam. An association of migration with CVD risk was observed for Ghanaian women living in London compared with those in rural Ghana (OR, 1.45; 95% CI, 1.04–2.01); adjustment for education, employment, and sources of income did not materially alter the risk estimate (Figure 2).
Figure 1. Logistic regression analysis of migration on elevated 10-y cardiovascular disease (≥7.5%) in men. Model 1: adjusted for education, employment, and sources of income. Model 2: model 1+physical activity and alcohol intake. Model 3: model 2+psychosocial stress. CI indicates confidence interval; LN, natural logarithmic function; and OR, odds ratio.
Figure 2. Logistic regression analysis of migration on elevated 10-y cardiovascular disease (≥7.5%) in women. Model 1: adjusted for education, employment, and sources of income. Model 2: model 1+physical activity and alcohol intake. Model 3: model 2+psychosocial stress. CI indicates confidence interval; LN, natural logarithmic function; and OR, odds ratio.
Among Ghanaians based in Europe, each additional year in length of stay was associated with 11% higher odds of elevated 10-year predicted risk of CVD in men (OR, 1.11; 95% CI, 1.09–1.13) and 9% in women (OR, 1.08; 95% CI, 1.06–1.10; Table 2). The effect size and strength of association were similar across the various European sites. On adjusting for age, education, employment, and sources of income, an increased risk of CVD was observed with increased length of stay in men (OR, 1.03; 95% CI, 1.01–1.06), whereas the effect in women was attenuated and no longer statistically significant (OR, 1.02; 95% CI, 0.99–1.04).
Table 2. Logistic Regression Analysis of Influence of Length of Stay in Europe on Risk of Elevated 10-Year Cardiovascular Disease Risk (≥7.5%)
VariablesOR (95% CI)
AmsterdamBerlinLondonAll
Men    
 Length of stay1.13 (1.10–1.17)*1.13 (1.09–1.18)*1.08 (1.04–1.11)*1.11 (1.09–1.13)*
 Multivariable    
  Model 11.06 (1.02–1.10)1.04 (0.99–1.10)1.01 (0.96–1.05)1.04 (1.01–1.06)
  Model 21.05 (1.00–1.09)1.03 (0.97–1.09)1.00 (0.95–1.06)1.03 (1.01–1.06)
Women    
 Length of stay1.09 (1.05–1.13)*1.06 (1.00–1.11)1.08 (1.06–1.11)*1.08 (1.06–1.10)*
 Multivariable    
  Model 11.01 (0.97–1.05)1.00 (0.95–1.06)1.02 (0.99–1.05)1.01 (0.99–1.04)
  Model 21.00 (0.96–1.05)1.01 (0.95–1.08)1.03 (0.99–1.07)1.02 (0.99–1.04)
Model 1: adjusted for age. Model 2: adjusted for age, education, employment, and source of income. CI indicates confidence interval; and OR, odds ratio.
*
P<0.001,
P<0.01,
P<0.05.

Discussion

Key Findings

This study has 3 important findings: first, the 10-year estimated risk of CVD is significantly increased for migrant Ghanaian men living in Amsterdam, 53.9%; Berlin, 61.0%; and urban Ghana, 45.4% compared with nonmigrants residing in rural Ghana, 34.7%. For men, the 10-year risk of CVD differed by city of residence in Europe, with the risk in men being higher in Berlin than in Amsterdam. For women, 10-year CVD risk was elevated in London; differences observed between Ghana, Berlin, and Amsterdam were minor. Secondly, modifiable risk factors of CVD are important contributors to differences in CVD between SSA migrant and home populations, as well as same migrant populations living in different European cities. Finally, for men, each additional year in length of stay in Europe increased 10-year predicted risk of CVD in European Ghanaian migrants.

Discussion of Key Findings

In this study, migrating to Europe increased the probability of elevated 10-year risk of CVD among Ghanaian men. Ghanaians in rural Ghana had lower CVD risk, which reflected better risk factor profile compared with urban Ghana and Ghanaian migrants in Europe. With the exception of current smoking in men, all risk factors were lower in rural Ghana. This corroborate findings from previous studies that looked at differences in CVD risk between residents in rural and urbanized cities in their respective countries or overseas.28,29
Contributory risk factors to increased CVD risk included BP levels, diabetes mellitus, and smoking, which were higher among the male migrant populations. This is consistent with previous studies, which showed an increase in CVD risk in migrant populations compared with their counterparts in their countries of origin.30,31 After controlling for education, employment, and sources of income, the effect between migrant and rural population increased in both men and women. In a subanalysis (Table II in the Data Supplement), the relationship between CVD risk and migration was similar across the various levels of attained education, with 10-year CVD risk being higher among the European sites and urban Ghana as compared with rural Ghana. Socioeconomic position has been observed to differ with regard to prevalence of diabetes mellitus among Ghanaians in different geographical locations32 highlighting a complex interaction of socioeconomic position and the development of diabetes mellitus. These findings suggest the need to consider socioeconomic variations in CVD risk predictions and management, particularly in ethnic minority populations. We also observed marked differences in BMI, which could partly explain the differences in CVD risk among these populations because a recent study that explored BMI among Ghanaian migrants and their home counterparts found increasing prevalence of obesity, with a rising gradient from rural Ghana to urban Ghana to Europe.23
Other lifestyle and behavioral changes after migration have been cited as possible explanation for increased CVD risk among migrant populations. In this study, we observed differences in physical activity and psychosocial stress between the migrants and their home counterparts. Physical activity, for instance, was higher in rural Ghana than all European cities and lowest in London. When adjusted for in the multivariable models, there was marginal attenuation of the effect size across sites, although the increased CVD risk in the European cities among men still remained. Previous studies among many diverse migrant populations, including SSA migrants, have also shown high risk of physical inactivity among these populations, partly explaining their increased risk of CVD.33,34 The effect of psychosocial stress was minimal and corroborates previous findings of nonsignificant influence of psychosocial stress on CVDs in this population.35 These risk factors, however, do not explain all the observed differences in CVD risk. Other risk factors, such as dietary habits after migration and adoption of Western dietary habits, linked to CVDs36 need to be further explored in this population.
The study also showed marked differences in risk of CVD between the cities of residence of European Ghanaian migrants, particularly in men. Elevated 10-year CVD risk among men was highest in Berlin (Germany) than Amsterdam (The Netherlands). Elevated CVD risk in Ghanaian migrants in the current study reflected the differences in the prevalence and burden of CVDs in the general population in these European countries, with CVD burden being highest in Germany (12.8%) and The Netherlands (9.7%).37 This finding in Ghanaian men is supportive of the contextual environment hypothesis, which postulates that the prevalence and risk factors of CVDs among migrant populations changes to reflect the existing trend in their host countries over time. This also means that a similar population of migrants residing in different countries could have different prevalence of diseases because they mirror the prevailing situation in that country as observed previously for prevalence of diabetes mellitus in African Caribbeans and South Asians residing in the United Kingdom and The Netherlands.13 Differences in diabetes mellitus prevalence among these migrant populations reflected differences in prevalence among their host countries (3.6% in the United Kingdom and 6.7% in The Netherlands),14 suggesting that contextual circumstances, which include socioeconomic development and access to and practice from healthcare and preventive services, vary significantly among the industrialized host countries of migrants and influence healthcare behavior and utilization.38 However, although CVD prevalence mirrors that of the host populations, overall, it has been found to be higher in the migrant populations than in the European host populations.30,39
Challenges in healthcare access among migrants may contribute to the contextual differences in CVD risk among migrant populations in different industrialized cities.8,40 Although this mostly affects newly arriving and undocumented migrants, health challenges in health provision, such as lack of knowledge about available services, language differences, and varying cultural attitudes to health and health care, can be persistent for migrants who have resided in their host countries for some time.40 An explorative study among Ghanaians in The Netherlands documented difficulties with the Dutch language and mistrust in healthcare providers as major barriers in access to health care.41 In Canada, new migrants receive access to health care within 3 months of arrival,8 whereas legal migrants in the United States have difficulties in accessing health insurance,42 and this has been cited as a possible contributor to lower cardiac risk factor score among migrants in Canada.8
As seen previously in studies elsewhere, marked differences for men and women were also observed for the RODAM study population.41,42 CVD risk was generally higher in men than in women at all sites, with the exception of rural Ghana. Sex differences in CVDs develop from sociocultural processes, such as differences in behaviors of women and men, different dietary habits after migration, lifestyles or stress, and different attitudes toward treatments and prevention.43,44 In general, men have a less-favorable cardiac risk factor profile than women (for example, smoking and high blood viscosity).43,44 As part of preventive efforts, these sex differences in CVD risk factors need to be considered when evaluating one’s probability of developing CVD.
This study shows an increased CVD risk with increasing length of stay in Europe, especially among Ghanaian men. This parallels other evidence of increased CVD risk factors among diverse migrant populations with increasing residence in the United States45,46 and suggests that migrants more frequently engage in unhealthy behaviors with longer stay in the host country, leading to increased risk of CVD among migrant populations. There is the need for prospective studies to better understand how acculturation processes influence health behaviors and outcomes. The influence of length of stay on health of migrants on CVD risk was not seen for Ghanaian women, which further outlines how sociocultural processes and environmental exposures manifest differently in men and women with respect to CVDs. In a study among ethnically diverse groups of United States immigrants, the odds of obesity/overweight and current smoking were greater for women than for men, whereas hyperlipidemia increased with increasing length of stay among men.46
A unique strength of RODAM is the homogenous study population of Ghanaians living in different settings in Africa and Europe. Previous studies, which attempted to assess the role of migration on CVD, used heterogeneous ancestry of populations who have left Africa long ago and now live in the Caribbean, United Kingdom, and United States.47 Focusing on one population, the limitations of heterogeneous ancestry of populations are dealt with by the RODAM study. However, given its cross-sectional nature, the correlation of predicted CVD risk with incident CVD events requires confirmation from prospective studies. The PCE risk algorithms use in predicting CVD in this study have not been yet validated for SSA populations. The risk factors of increased CVD risk observed could not explain all the differences between migrant and home populations. Further studies into dietary habits, access to health services, acculturation and integration, and origin of migration are recommended.
Although across all sites, well-standardized approaches for measurement procedures were applied, the recruitment strategies had to be adapted to local circumstances as a result of different civil registration systems in the various countries. As suggested in previous studies on the effect of nonresponse on CVD risk analysis, study participants are a somewhat biased subset of the target population because they tend to over-represent those with risk factors but without the disease, referred to as the worried well. This represents independent bias in both risk factor and disease distribution, and could produce minor to moderate errors in odds of CVD risk calculated in this study.48 Nonrespondent analysis undertaken, however, showed a fairly similar distribution of respondents and nonrespondents in Berlin. Evidence suggests that most Ghanaians in Europe are affiliated with Ghanaian organizations,49 indicating that members of these organizations may be representative of the Ghanaian population residing in various European cities and rendering bias of CVD risk factor differences between European sites by the variation in sampling strategy unlikely.

Conclusions

In conclusion, this study indicates profound 10-year increased risk of CVD among Ghanaians residing in urban Ghana and urbanized cities in Europe. This calls for imperative efforts to disentangle the important predictors of increased CVD risk among SSA migrants in Europe and nonmigrants in urban centers to inform targeted health care and interventions. The risk of CVD was also observed to be different among similar populations of the same ancestry residing in different industrialized European countries, suggesting the need to take into account the contextual differences in studying the causes of increased CVD risk among homogenous migrant populations.

Acknowledgments

We are grateful to the research assistants, interviewers, and other staff of the 5 research locations who have taken part in gathering the data and, most of all, the Ghanaian volunteers participating in the RODAM study (Research on Obesity and Diabetes Among African Migrants). We gratefully acknowledge the advisory board members for their valuable support in shaping the RODAM study methods, Jan van Straalen from the Academic Medical Centre with standardization of the laboratory procedures, and the Academic Medical Centre Biobank for their support in biobank management and high-quality storage of collected samples. We are also grateful to Peter Zuithoff from the Julius Centre, University Medical Centre Utrecht, for the support and contribution to the data analysis. D. Boateng and Drs Klipstein-Grobusch and Agyemang contributed to the design of the work. D. Boateng and Drs Agyemang, Klipstein-Grobusch, Beune, Kengne, Grobbee, Smeeth, Schulze, and Stronks contributed to the analysis and interpretation of data for the work. D. Boateng and Drs Klipstein-Grobusch and Agyemang drafted the article. Drs Agyemang, Beune, Meeks, Stronks, de-Graft Aikins, Agyei-Baffour, Owuso-Dabo, Bahendeka, Danquah, Galbete, Schulze, Spranger, Mockenhaupt, Addo, Smeeth, and Klipstein-Grobusch contributed to aquisition of the data. All authors have critically revised the article, gave final approval and agreed to be accountable for all aspects of work ensuring integrity and accuracy.

Supplemental Material

File (circcvqo_circcqo-2017-004013_supp1.pdf)

References

1.
Bradby H, Humphris R, Newall D, Phillimore JPublic Health Aspects of Migrant Health: A Review of the Evidence on Health Status for Refugees and Asylum Seekers in the European Region. Copenhagen, Denmark: WHO Europe; 2015.
2.
Rechel B, Mladovsky P, Ingleby D, Mackenbach JP, McKee M. Migration and health in an increasingly diverse Europe. Lancet. 2013;381:1235–1245. doi: 10.1016/S0140-6736(12)62086-8.
3.
Stern R, Puoane T, Tsolekile L. An exploration into the determinants of noncommunicable diseases among rural-to-urban migrants in periurban South Africa. Prev Chronic Dis. 2010;7:A131.
4.
Bo A, Zinckernagel L, Krasnik A, Petersen JH, Norredam M. Coronary heart disease incidence among non-Western immigrants compared to Danish-born people: effect of country of birth, migrant status, and income. Eur J Prev Cardiol. 2015;22:1281–1289. doi: 10.1177/2047487314551538.
5.
Agyemang C, Addo J, Bhopal R, Aikins Ade G, Stronks K. Cardiovascular disease, diabetes and established risk factors among populations of sub-Saharan African descent in Europe: a literature review. Global Health. 2009;5:7. doi: 10.1186/1744-8603-5-7.
6.
Misra A, Ganda OP. Migration and its impact on adiposity and type 2 diabetes. Nutrition. 2007;23:696–708. doi: 10.1016/j.nut.2007.06.008.
7.
Agyemang C, Kieft S, Snijder MB, Beune EJ, van den Born BJ, Brewster LM, Ujcic-Voortman JJ, Bindraban N, van Montfrans G, Peters RJ, Stronks K. Hypertension control in a large multi-ethnic cohort in Amsterdam, The Netherlands: the HELIUS study. Int J Cardiol. 2015;183:180–189. doi: 10.1016/j.ijcard.2015.01.061.
8.
Tu J V, Chu A, Rezai MR, Guo H, Maclagan LC, Austin PC, Booth GL, Manuel DG, Chiu M, Ko DT, Lee DS, Shah BR, Donovan LR, Sohail QZ, Alter DA. The incidence of major cardiovascular events in immigrants to Ontario, Canada: the CANHEART Immigrant Study. Circulation. 2015;132:1549.
9.
Theorell T, Kristensen T, Kornitzer M, Marmot M, Orth-Gomér K, Steptoe AStress and Cardiovascular Disease 2006. Brussels, Belgium: European Heart Network; 2006.
10.
Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–1350. doi: 10.1056/NEJM200105033441801.
11.
Bedi US, Singh S, Syed A, Aryafar H, Arora R. Coronary artery disease in South Asians: an emerging risk group. Cardiol Rev. 2006;14:74–80. doi: 10.1097/01.crd.0000182411.88146.72.
12.
Dawson AJ, Sundquist J, Johansson SE. The influence of ethnicity and length of time since immigration on physical activity. Ethn Health. 2005;10:293–309. doi: 10.1080/13557850500159965.
13.
Agyemang C, Kunst AE, Bhopal R, Anujuo K, Zaninotto P, Nazroo J, Nicolaou M, Unwin N, van Valkengoed I, Redekop WK, Stronks K. Diabetes prevalence in populations of South Asian Indian and African origins: a comparison of England and the Netherlands. Epidemiology. 2011;22:563–567. doi: 10.1097/EDE.0b013e31821d1096.
14.
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:4–14. doi: 10.1016/j.diabres.2009.10.007.
15.
Manna DR, Bruijnzeels MA, Mokkink HG, Berg M. Ethnic specific recommendations in clinical practice guidelines: a first exploratory comparison between guidelines from the USA, Canada, the UK, and the Netherlands. Qual Saf Health Care. 2003;12:353–358.
16.
Cooney MT, Dudina A, D’Agostino R, Graham IM. Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future? Circulation. 2010;122:300–310. doi: 10.1161/CIRCULATIONAHA.109.852756.
17.
World Health Organization. Prevention of Cardiovascular Disease Guidelines for Assessment and Management of Cardiovascular Risk WHO Library Cataloguing-in-Publication Data. Geneva, Switzerland: World Health Organization; 2007.
18.
Siontis GC, Tzoulaki I, Siontis KC, Ioannidis JP. Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ. 2012;344:e3318. doi: 10.1136/bmj.e3318.
19.
Kengne AP, Patel A, Colagiuri S, Heller S, Hamet P, Marre M, Pan CY, Zoungas S, Grobbee DE, Neal B, Chalmers J, Woodward M; ADVANCE Collaborative Group. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. Diabetologia. 2010;53:821–831. doi: 10.1007/s00125-010-1681-4.
20.
Dalton AR, Bottle A, Soljak M, Majeed A, Millett C. Ethnic group differences in cardiovascular risk assessment scores: national cross-sectional study. Ethn Health. 2014;19:367–384. doi: 10.1080/13557858.2013.797568.
21.
Muntner P, Colantonio LD, Cushman M, Goff DC, Howard G, Howard VJ, Kissela B, Levitan EB, Lloyd-Jones DM, Safford MM. Validation of the atherosclerotic cardiovascular disease Pooled Cohort risk equations. JAMA. 2014;311:1406–1415. doi: 10.1001/jama.2014.2630.
22.
Goff DC, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O’Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC, Sorlie P, Stone NJ, Wilson PW; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2014;63(25 pt B):2935–2959. doi: 10.1016/j.jacc.2013.11.005.
23.
Agyeman C, Meeks M, Beune E, Owusu-Dabo E, Mockenhaupt FP, Addo J, de-Graft Aikins A, Bahendeka S, Danquah I, Schulze MB, Spranger J, Burr T, Adjei Balfour P, Amoah SK, Ga, lbete C, Henneman P, Klipstein-Grobusch K, Nicolau M, Adeyemo A, van Straalen J, Smeeth L, Stronks K. Obesity and type 2 diabetes in sub-Saharan Africans - is the burden in today’s Africa similar to African migrants in Europe? The RODAM study. BMC Med. 2016;14:166. doi: 10.1186/s12916-016-0709-0.
24.
Agyemang C, Beune E, Meeks K, Owusu-Dabo E, Agyei-Baffour P, Aikins Ad, Dodoo F, Smeeth L, Addo J, Mockenhaupt FP, Amoah SK, Schulze MB, Danquah I, Spranger J, Nicolaou M, Klipstein-Grobusch K, Burr T, Henneman P, Mannens MM, van Straalen JP, Bahendeka S, Zwinderman AH, Kunst AE, Stronks K. Rationale and cross-sectional study design of the research on obesity and type 2 diabetes among African migrants: the RODAM study. BMJ Open. 2014;4:e004877. doi: 10.1136/bmjopen-2014-004877.
25.
World Health Organization. Waist Circumference and Waist-Hip Ratio Report of a WHO Expert Consultation. Geneva, Switzerland: World Health Organization; 2011.
26.
Bull FC, Maslin TS, Armstrong T. Global physical activity questionnaire (GPAQ): nine country reliability and validity study. J Phys Act Health. 2009;6:790–804.
27.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC, Watson K, Wilson PW, Eddleman KM, Jarrett NM, LaBresh K, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC, Tomaselli GF; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 suppl 2):S1–S45. doi: 10.1161/01.cir.0000437738.63853.7a.
28.
Kodaman N, Aldrich MC, Sobota R, Asselbergs FW, Poku KA, Brown NJ, Moore JH, Williams SM. Cardiovascular disease risk factors in Ghana during the rural-to-urban transition: a cross-sectional study. PLoS One. 2016;11:e0162753. doi: 10.1371/journal.pone.0162753.
29.
Miranda JJ, Gilman RH, Smeeth L. Differences in cardiovascular risk factors in rural, urban and rural-to-urban migrants in Peru. Heart. 2011;97:787–796.
30.
Agyemang C, Bindraban N, Mairuhu G, Montfrans Gv, Koopmans R, Stronks K; SUNSET (Surinamese in The Netherlands: Study on Ethnicity and Health) Study Group. Prevalence, awareness, treatment, and control of hypertension among Black Surinamese, South Asian Surinamese and White Dutch in Amsterdam, The Netherlands: the SUNSET study. J Hypertens. 2005;23:1971–1977.
31.
Patel JV, Vyas A, Cruickshank JK, Prabhakaran D, Hughes E, Reddy KS, Mackness MI, Bhatnagar D, Durrington PN. Impact of migration on coronary heart disease risk factors: comparison of Gujaratis in Britain and their contemporaries in villages of origin in India. Atherosclerosis. 2006;185:297–306. doi: 10.1016/j.atherosclerosis.2005.06.005.
32.
Addo J, Agyemang C, de-Graft Aikins A, Beune E, Schulze MB, Danquah I, Galbete C, Nicolaou M, Meeks K, Klipstein-Grobusch K, Bahendaka S, Mockenhaupt FP, Owusu-Dabo E, Kunst A, Stronks K, Smeeth L. Association between socioeconomic position and the prevalence of type 2 diabetes in Ghanaians in different geographic locations: the RODAM study. J Epidemiol Community Health. 2017;71:633–639. doi: 10.1136/jech-2016-208322.
33.
Payne W, Harvey J, Dharmage SImmigrant Physical Activity Study 2010: Report to the Victorian Health Promotion Foundation. Ballarat, Victoria: University of Ballarat; 2011.
34.
Commodore-Mensah Y, Hill M, Allen J, Cooper LA, Blumenthal R, Agyemang C, Himmelfarb CD. Sex differences in cardiovascular disease risk of Ghanaian- and Nigerian-born West African immigrants in the United States: the Afro-Cardiac Study. J Am Heart Assoc. 2016;5:e002385.
35.
Agyei B, Nicolaou M, Boateng L, Dijkshoorn H, van den Born BJ, Agyemang C. Relationship between psychosocial stress and hypertension among Ghanaians in Amsterdam, the Netherlands–the GHAIA study. BMC Public Health. 2014;14:692. doi: 10.1186/1471-2458-14-692.
36.
Regev-Tobias H, Reifen R, Endevelt R, Havkin O, Cohen E, Stern G, Stark A. Dietary acculturation and increasing rates of obesity in Ethiopian women living in Israel. Nutrition. 2012;28:30–34. doi: 10.1016/j.nut.2011.02.010.
37.
Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37:3232–3245. doi: 10.1093/eurheartj/ehw334.
38.
Marques TV. Refugees and migrants struggle to obtain health care in Europe. CMAJ. 2012;184:E531–E532. doi: 10.1503/cmaj.109-4214.
39.
Agyemang C, Nicolaou M, Boateng L, Dijkshoorn H, van de Born BJ, Stronks K. Prevalence, awareness, treatment, and control of hypertension among Ghanaian population in Amsterdam, The Netherlands: the GHAIA study. Eur J Prev Cardiol. 2013;20:938–946. doi: 10.1177/2047487312451540.
40.
Stanciole AE, Huber MAccess to Health Care for Migrants, Ethnic Minorities, and Asylum Seekers in Europe Migration and Health in Europe. Vienna, Austria: European Centre for Social Welfare Policy and Research; 2009.
41.
Boateng L, Nicolaou M, Dijkshoorn H, Stronks K, Agyemang C. An exploration of the enablers and barriers in access to the Dutch healthcare system among Ghanaians in Amsterdam. BMC Health Serv Res. 2012;12:75. doi: 10.1186/1472-6963-12-75.
42.
Parmet WE. Holes in the safety net–legal immigrants’ access to health insurance. N Engl J Med. 2013;369:596–598. doi: 10.1056/NEJMp1306637.
43.
Regitz-Zagrosek V, Oertelt-Prigione S, Prescott E, Franconi F, Gerdts E, Foryst-Ludwig A, Maas AH, Kautzky-Willer A, Knappe-Wegner D, Kintscher U, Ladwig KH, Schenck-Gustafsson K, Stangl V; The Eugenmed, Cardiovascular Clinical Study Group. Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes. Eur Heart J. 2016;37:24–34. doi: 10.1093/eurheartj/ehv598.
44.
Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37:278–316. doi: 10.1210/er.2015-1137.
45.
Goel MS, McCarthy EP, Phillips RS, Wee CC. Obesity among us immigrant subgroups by duration of residence. JAMA. 2004;292:2860–2867.
46.
Koya DL, Egede LE. Association between length of residence and cardiovascular disease risk factors among an ethnically diverse group of United States immigrants. J Gen Intern Med. 2007;22:841–846. doi: 10.1007/s11606-007-0163-y.
47.
Mbanya JC, Cruickshank JK, Forrester T, Balkau B, Ngogang JY, Riste L, Forhan A, Anderson NM, Bennett F, Wilks R. Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain. Diabetes Care. 1999;22:434–440.
48.
Criqui MH, Austin M, Barrett-Connor E. The effect of non-response on risk ratios in a cardiovascular disease study. J Chronic Dis. 1979;32:633–638.
49.
Elam G, Chinouya M. Feasibility study for health surveys among Black African populations living in the UK : stage 2 - diversity among Black African communities. London, UK: Department of Health; 2000.

Information & Authors

Information

Published In

Go to Circulation: Cardiovascular Quality and Outcomes
Go to Circulation: Cardiovascular Quality and Outcomes
Circulation: Cardiovascular Quality and Outcomes
PubMed: 29150534

History

Received: 18 June 2017
Accepted: 5 October 2017
Published in print: November 2017
Published online: 17 November 2017

Permissions

Request permissions for this article.

Keywords

  1. cardiovascular diseases
  2. Ghana
  3. human migration
  4. risk factors
  5. transients and migrants

Subjects

Authors

Affiliations

Daniel Boateng, MPH, MSc
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Charles Agyemang, MPH, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Erik Beune, MSc, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Karlijn Meeks, MSc, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Liam Smeeth, MD, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Matthias Schulze, MSc, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Juliet Addo, MD, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Ama de-Graft Aikins, MSc, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Cecilia Galbete, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Silver Bahendeka, MD, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Ina Danquah, MSc, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Peter Agyei-Baffour, MSc, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Ellis Owusu-Dabo, MD, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Frank P. Mockenhaupt, MD, PhD;
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Joachim Spranger, MD, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Andre P. Kengne, MD, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Diederick E. Grobbee, MD, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Karien Stronks, MSc, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).
Kerstin Klipstein-Grobusch, MSc, PhD
From Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands (D.B., D.E.G., K.K.-G.); School of Public Health, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana (D.B., P.A.B., E.O.-D.); Department of Public Health, Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, The Netherlands (C.A., E.B., K.M., K.S.); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom (L.S., J.A.); Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany (M.S., C.G., I.D.); Regional Institute for Population Studies, University of Ghana, Legon, Ghana (A.d.-G.A.); Mother Kevin Postgraduate Medical School, Uganda Martyrs University, Kampala (S.B.); Kumasi Centre for Collaborative Research, Kwame NKrumah University of Science and Technology, Ghana (E.O.-D.); Institute of Tropical Medicine and International Health, Charité–University Medicine Berlin, Germany (F.P.M.); Charite Center for Cardiovascular Research, Berlin, Germany (J.S.); Non-Communicable Disease Research Unit, South African Medical Research Council, Cape Town, South Africa (A.P.K.); and Division of Epidemiology and Biostatistics, School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa (K.K.-G.).

Notes

Correspondence to Daniel Boateng, MPH, MSc, Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, Huispost nr STR 6.131, P.O. Box 85500, 3584 CG, Utrecht, The Netherlands. E-mail [email protected]

Disclosures

None.

Sources of Funding

The RODAM study (Research on Obesity and Diabetes Among African Migrants) was supported by the European Commission under the Framework Programme (grant number 278901). Dr Galbete is supported by NutriAct—Competence Cluster Nutrition Research Berlin—Potsdam funded by the German Federal Ministry of Education and Research (FKZ: 01EA1408A-G). D. Boateng is supported by University Medical Centre Utrecht Global Health Support Program.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

  1. Unhealthy diets increase the likelihood of being overweight or obese among African migrant students in China, but not among African non-migrant students: a cross-sectional study, Frontiers in Nutrition, 11, (2024).https://doi.org/10.3389/fnut.2024.1291360
    Crossref
  2. Chronic conditions and multimorbidity among West African migrants in greater Barcelona, Spain, Frontiers in Public Health, 11, (2023).https://doi.org/10.3389/fpubh.2023.1142672
    Crossref
  3. Kardiovaskuläre Erkrankungen, Depression, Angst, traumatischer Stress und internistische Erkrankungen, (105-185), (2023).https://doi.org/10.1007/978-3-662-65873-4_2
    Crossref
  4. Socioeconomic Determinants of Cardiovascular Diseases, Obesity, and Diabetes among Migrants in the United Kingdom: A Systematic Review, International Journal of Environmental Research and Public Health, 19, 5, (3070), (2022).https://doi.org/10.3390/ijerph19053070
    Crossref
  5. Aetiological research on the health of migrants living in Germany: a systematic literature review, BMJ Open, 12, 6, (e058712), (2022).https://doi.org/10.1136/bmjopen-2021-058712
    Crossref
  6. Health and illness in migrants and refugees arriving in Europe: analysis of the electronic Personal Health Record system, Journal of Travel Medicine, (2022).https://doi.org/10.1093/jtm/taac035
    Crossref
  7. Transitioning food environments and diets of African migrants: implications for non-communicable diseases, Proceedings of the Nutrition Society, 82, 1, (69-79), (2022).https://doi.org/10.1017/S0029665122002828
    Crossref
  8. Association between Practising Religion and Cardiovascular Disease Risk among Ghanaian Non-Migrants and Migrants in Europe: The RODAM Study, International Journal of Environmental Research and Public Health, 18, 5, (2451), (2021).https://doi.org/10.3390/ijerph18052451
    Crossref
  9. Multimorbidity Among Migrant and Non-Migrant Ghanaians: The RODAM Study, International Journal of Public Health, 66, (2021).https://doi.org/10.3389/ijph.2021.1604056
    Crossref
  10. DNA Methylation as the Link between Migration and the Major Noncommunicable Diseases: the RODAM Study, Epigenomics, 13, 9, (653-666), (2021).https://doi.org/10.2217/epi-2020-0329
    Crossref
  11. See more
Loading...

View Options

View options

PDF and All Supplements

Download PDF and All Supplements

PDF/EPUB

View PDF/EPUB
Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to access the full text.

Purchase access to this article for 24 hours

Migration and Cardiovascular Disease Risk Among Ghanaian Populations in Europe:
Circulation: Cardiovascular Quality and Outcomes
  • Vol. 10
  • No. 11

Purchase access to this journal for 24 hours

Circulation: Cardiovascular Quality and Outcomes
  • Vol. 10
  • No. 11
Restore your content access

Enter your email address to restore your content access:

Note: This functionality works only for purchases done as a guest. If you already have an account, log in to access the content to which you are entitled.

Media

Figures

Other

Tables

Share

Share

Share article link

Share

Comment Response